Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year

D Houpe1, M Peltier, A Cohen-Solal

  • 1Department of Cardiology, South Hospital, Amiens, France.

Insights

Treatment for heart failure (HF) with reduced ejection fraction largely uses diuretics and ACE inhibitors. However, beta-blocker use remains low in both patient numbers and prescribed dosages, indicating a need for better guideline adherence.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Pharmacology

Background:

  • Guidelines for heart failure (HF) with left ventricular systolic dysfunction exist but are not consistently applied in practice.
  • The ETICS study aimed to assess medical treatment adherence in HF patients post-hospitalization.

Purpose of the Study:

  • To evaluate the prescription patterns of HF medications at discharge and one year post-hospitalization.
  • To identify areas of underutilization of guideline-recommended therapies.

Main Methods:

  • Prospective inclusion of 179 patients (63% male, mean age 69±13 years) with ejection fraction ≤ 40%.
  • Primary etiology of HF was ischemic heart disease (44%).
  • Medication use and dosages were recorded at discharge and 1-year follow-up.

Main Results:

  • Loop diuretics (95%) and ACE inhibitors (82%) were highly prescribed at discharge.
  • Beta-blocker prescription increased from 25% at discharge to 41% at 1 year, but dosages remained suboptimal (26% and 35% of recommended, respectively).
  • Spironolactone use was consistent (35-37%), while digitalis and nitrates saw decreased use.

Conclusions:

  • Diuretics and ACE inhibitors are widely used for HF with left ventricular systolic dysfunction.
  • Beta-blockers are underutilized in terms of patient numbers and prescribed doses.
  • Enhanced dissemination of clinical practice guidelines is crucial for improving HF management.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...